BL
BSX icon

Balentine LLC’s Boston Scientific BSX Stock Holding History

Balentine LLC’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-4,981
Closed -$249K – 577
2023
Q1 		$249K Buy
4,981
+618
+14% +$29.1K 0.01% 466
2022
Q4 		$202K Buy
+4,363
New +$189K 0.01% 542
2022
Q3 		– Sell
-8,013
Closed -$299K – 618
2022
Q2 		$299K Sell
8,013
-4,023
-33% -$164K 0.01% 431
2022
Q1 		$533K Buy
+12,036
New +$522K 0.02% 280
2021
Q4 		– Sell
-4,634
Closed -$201K – 428
2021
Q3 		$201K Buy
+4,634
New +$205K 0.01% 237
2020
Q3 		– Sell
-413
Closed -$15K – 246
2020
Q2 		$15K Buy
413
+151
+58% +$5.44K ﹤0.01% 446
2020
Q1 		$9K Sell
262
-1,738
-87% -$67.9K ﹤0.01% 381
2019
Q4 		$90K Buy
2,000
+1,713
+597% +$71.7K 0.01% 128
2019
Q3 		$12K Buy
287
+84
+41% +$3.56K ﹤0.01% 305
2019
Q2 		$9K Buy
+203
New +$7.81K ﹤0.01% 324
2018
Q1 		– Sell
-609
Closed -$15K – 126
2017
Q4 		$15K Buy
+609
New +$16.8K ﹤0.01% 421

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Balentine LLC's BSX Position: Q2 2023 in Review

Balentine LLC sold out of Boston Scientific (BSX) in Q2 2023, closing a stake of 4,981 shares — an estimated $249K sold.

Balentine LLC first reported a position in BSX in Q4 2017 and held it in 11 quarters. The position peaked at $533K in Q1 2022. 1,066 funds tracked by Wall St. Rank hold BSX as of Q2 2023.

  • Balentine LLC reported no remaining Boston Scientific position as of Q2 2023 after selling out during the quarter.
  • Balentine LLC sold 4,981 Boston Scientific shares in Q2 2023, an estimated $249K.
  • Balentine LLC first reported a position in Boston Scientific in Q4 2017 and held it in 11 quarters.
  • Balentine LLC's Boston Scientific position peaked at $533K in Q1 2022.
  • 1,066 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2023.

Based on Balentine LLC's 13F filing for Q2 2023, filed 14 Aug 2023.